Publicacións (160) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

filter_list

2024

  1. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system

    Obesity, Vol. 32, Núm. 4, pp. 710-722

  2. Association between endocrine and neuropsychological endophenotypes and gambling disorder severity

    Addictive Behaviors, Vol. 153

  3. Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis

    Comprehensive Psychiatry, Vol. 128

  4. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  5. Correction to: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits (Nature Reviews Endocrinology, (2024), 20, 4, (189-190), 10.1038/s41574-024-00955-3)

    Nature Reviews Endocrinology

  6. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  7. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    DIABETES THERAPY, Vol. 15, Núm. 5, pp. 1069-1084

  8. Estrogen receptor-α signaling in tanycytes lies at the crossroads of fertility and metabolism

    Metabolism: Clinical and Experimental, Vol. 158

  9. Formulation of protein-loaded nanoparticles via freeze-drying

    Drug Delivery and Translational Research, Vol. 14, Núm. 12, pp. 3640-3653

  10. GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1